Lexpos News

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Levobunolol (Betagan®) 0.5% eye drops 0.4ml unit dose preservative free. MSN/2024/108 Tier 2 – medium impact Date of issue: 20th November 2024 Levobunolol (Betagan®) 0.5% eye drops 0.4ml unit dose preservative free are being discontinued from late December 2024 Alternative preservative [...]

The post Medicine Supply Notification: Levobunolol (Betagan®) 0.5% eye drops 0.4ml unit dose preservative free appeared first on Community Pharmacy England.

As ‘FS’ endorsed prescription items become more common, Community Pharmacy England has released updated guidance on how pharmacies should handle these prescriptions. Community pharmacies are seeing an increase in electronic prescriptions with items endorsed ‘FS’ for free supply of sexual health treatment. This increase has been partially driven by the adoption of EPS by sexual [...]

The post Guidance on handling ‘FS’ endorsed prescriptions for free supply of sexual health treatments appeared first on Community Pharmacy England.

The NHS Vaccination Strategy, published in December last year, set out an intention for NHS England, the Department of Health and Social Care (DHSC) and the UK Health Security Agency (UKHSA) to explore the potential benefits of adopting centralisation of adult flu vaccine procurement and supply. If that approach is adopted, it would mean flu [...]

The post NHS England seek your views on central procurement of flu vacs appeared first on Community Pharmacy England.

Pharmacy owners have one day left to apply to provide the COVID-19 vaccination service from April 2025, as the deadline for submissions is 11:59pm on 19th November 2024. This process only applies to: Pharmacies not already contracted to provide the service and wishing to apply to provide it from April 2025; and Pharmacies already contracted [...]

The post Reminder: C-19 vac – One day left to submit application for provision from April 2025 appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Information: Entyvio 108mg solution for injection in pre-filled syringe (Takeda UK Limited) Drug alert number: EL (24)A/55 Date issued: 18 November 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Entyvio 108mg solution for injection in pre-filled syringe Company name: [...]

The post MHRA Class 4 Medicines Defect Information: Entyvio 108mg solution for injection in pre-filled syringe (Takeda UK Limited) appeared first on Community Pharmacy England.